Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Archives of Drug Information|January 12, 2011
The Dose Proportionality of Telcagepant after Administration of Single Oral and Intravenous Doses in Healthy Adult SubjectsTae H Han, Rebecca L Blanchard, John Palcza, et al.Clinical and Translational Science|January 4, 2020
Ubrogepant Is Not Associated With Clinically Meaningful Elevations of Alanine Aminotransferase in Healthy Adult MalesWendy Ankrom, Phung Bondiskey, Chi-Chung Li, et al.Cancer Chemotherapy and Pharmacology|February 1, 2012
The effect of multiple doses of rifampin and ketoconazole on the single-dose pharmacokinetics of ridaforolimusMark Stroh, John Palcza, Jacqueline McCrea, et al.Clinical Pharmacology and Therapeutics|October 23, 2018
Pharmacokinetics and Pharmacodynamics of the BACE1 Inhibitor Verubecestat (MK-8931) in Healthy Japanese Adults: A Randomized, Placebo-Controlled StudyK Chris Min, Marissa F Dockendorf, John Palcza, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 16, 2015
Grazoprevir, Elbasvir, and Ribavirin for Chronic Hepatitis C Virus Genotype 1 Infection After Failure of Pegylated Interferon and Ribavirin With an Earlier-Generation Protease Inhibitor: Final 24-Week Results From C-SALVAGEMaria Buti, Stuart C Gordon, Eli Zuckerman, et al.Journal of Hepatology|April 22, 2015
Grazoprevir and elbasvir plus ribavirin for chronic HCV genotype-1 infection after failure of combination therapy containing a direct-acting antiviral agentXavier Forns, Stuart C Gordon, Eli Zuckerman, et al.Journal of Clinical Pharmacology|May 16, 2014
Lack of meaningful effect of ridaforolimus on the pharmacokinetics of midazolam in cancer patients: model prediction and clinical confirmationMark Stroh, Jennifer Talaty, Punam Sandhu, et al.Psychopharmacology|July 18, 2016
On-the-road driving performance the morning after bedtime use of suvorexant 15 and 30 mg in healthy elderlyAnnemiek Vermeeren, Eva Vets, Eric F P M Vuurman, et al.British Journal of Clinical Pharmacology|November 8, 2014
Characterizing the PK/PD relationship for inhibition of capsaicin-induced dermal vasodilatation by MK-3207, an oral calcitonin gene related peptide receptor antagonistChi-Chung Li, Steve Vermeersch, William S Denney, et al.Sleep|June 4, 2015
On-the-Road Driving Performance the Morning after Bedtime Use of Suvorexant 20 and 40 mg: A Study in Non-Elderly Healthy VolunteersAnnemiek Vermeeren, Hong Sun, Eric F P M Vuurman, et al.Pageof 3